Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · IEX Real-Time Price · USD
2.27
+0.07 (3.18%)
May 31, 2023, 4:00 PM EDT - Market closed
Stereotaxis Market Cap
Stereotaxis has a market cap or net worth of $183.14 million as of June 1, 2023. Its market cap has increased by 37.08% in one year.
Market Cap
183.14M
Enterprise Value
162.11M
1-Year Change
37.08%
Ranking
Category
Stock Price
$2.27
Market Cap Chart
Since August 12, 2004, Stereotaxis's market cap has increased from $183.10M to $183.14M, an increase of 0.02%. That is a compound annual growth rate of 0.00%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2023 | 177.50M | -0.89% |
May 26, 2023 | 179.10M | 5.73% |
May 25, 2023 | 169.40M | -0.47% |
May 24, 2023 | 170.20M | 1.92% |
May 23, 2023 | 167.00M | -4.19% |
May 22, 2023 | 174.30M | -3.97% |
May 19, 2023 | 181.50M | 33.16% |
May 18, 2023 | 136.30M | - |
May 17, 2023 | 136.30M | -4.01% |
May 16, 2023 | 142.00M | 4.80% |
May 15, 2023 | 135.50M | -2.38% |
May 12, 2023 | 138.80M | 6.28% |
May 11, 2023 | 130.60M | -2.76% |
May 10, 2023 | 134.30M | 3.47% |
May 9, 2023 | 129.80M | -1.74% |
May 8, 2023 | 132.10M | -3.79% |
May 5, 2023 | 137.30M | 3.94% |
May 4, 2023 | 132.10M | - |
May 3, 2023 | 132.10M | - |
May 2, 2023 | 132.10M | - |
May 1, 2023 | 132.10M | 6.02% |
Apr 28, 2023 | 124.60M | -1.19% |
Apr 27, 2023 | 126.10M | -0.55% |
Apr 26, 2023 | 126.80M | -2.91% |
Apr 25, 2023 | 130.60M | -1.14% |
View and export this data all the way back to 2004.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Actinium Pharmaceuticals, Inc. | 216.30M |
InfuSystem Holdings, Inc. | 186.29M |
Asensus Surgical, Inc. | 122.61M |
CEL-SCI Corporation | 111.34M |
Electromed, Inc. | 102.73M |
VolitionRx Limited | 91.61M |
Matinas BioPharma Holdings, Inc. | 91.27M |
Cybin Inc. | 55.35M |
Armata Pharmaceuticals, Inc. | 48.43M |
Retractable Technologies, Inc. | 35.63M |